-
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
lilly
March 27, 2017
Jointly developed research projects will study diabetes healthcare outcomes for the Latino population
-
New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart fa
worldpharmanews
March 21, 2017
Novartis has announced results of a new post-hoc analysis in a subgroup of patients with reduced ejection fraction heart failure (HFrEF) and diabetes...
-
Branded heart, diabetes drugs much costlier than generic ones
financialexpress
March 13, 2017
The minster also mentioned that in the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic drugs in Jan Aushadhi Kendras
-
Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR?'
lilly
March 06, 2017
NASCAR? and Lilly Diabetes announced today that Lilly is expanding its involvement in NASCAR with a multi-year official partnership with the sanctioning body.
-
MSD, Wayra unveil Velocity Health winners
pharmatimes
February 23, 2017
Merck Sharp & Dohme (MSD) and Wayra UK have unveiled the 2017 winners of Velocity Health, a ground-breaking preventative digital healthcare accelerator programme designed to address key care challenges.
-
Weight-Loss Surgery May Help Obese Patients Beat Diabetes
drugs.com
February 16, 2017
There's more evidence that obese patients with type 2 diabetes can control the disease better with weight-loss surgery, compared to medication alone.
-
Boehringer, Inovalon Enter Cloud Platform Pact
contractpharma
January 24, 2017
Aims to support greater customer insight, data integration and analytics
-
EU approval for c’s type 2 diabetes treatment
europeanpharmaceuticalreview
January 20, 2017
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 di
-
Study Ties Inflammation, Gut Bacteria to Type 1 Diabetes
drugs.com
January 20, 2017
People with type 1 diabetes show changes in their digestive system that aren't seen in people who don't have the autoimmune disease, a new Italian study finds.
-
Drugmakers partner to tackle non-communicable diseases in developing countries
firstwordpharma
January 19, 2017
More than 20 pharmaceutical companies on Wednesday launched a project termed Access Accelerated to tackle non-communicable diseases (NCDs) such as cancer and diabetes in low and lower-middle income countries.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
